tradingkey.logo
tradingkey.logo
Search

Coya Therapeutics Inc

COYA
Add to Watchlist
3.130USD
-0.140-4.28%
Close 11-13 16:00(ET)
73.43MMarket Cap
LossP/E TTM
After-hours 16:00 (ET)3.130USD-0.010-0.32%

COYA Financials

See Coya Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
73.43M
Dividend TTM
0.00
P/E TTM
-2.71
EPS TTM
-1.15
Revenue
7.95M
Net Profit
-14.88M
ROE
-51.31%
ROA
-46.09%
Coya Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.28/-0.34
Revenue / Forecast
243.75K/100.00K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-257.95%-0.45
22.35%-0.28
27.17%-0.32
-91.28%-0.34
52.14%-0.13
-87.97%-0.36
-25.06%-0.44
-255.38%-0.18
23.20%-0.26
37.69%-0.19
-24.14%-0.35
139.99%0.11
---0.34
---0.31
---0.28
---0.29
----
----
----
----
Revenue
-93.43%234.13K
48.97%243.75K
-2.61%251.15K
202768.80%3.96M
--3.56M
-95.22%163.62K
103.32%257.88K
-99.97%1.95K
--0.00
--3.43M
--126.84K
--6.00M
----
----
----
----
----
----
----
----
Net Profit
-401.82%-10.62M
-8.91%-6.64M
1.37%-7.21M
-95.78%-5.71M
47.39%-2.12M
-110.78%-6.09M
-44.63%-7.31M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
140.74%1.27M
14.89%-3.42M
9.30%-3.10M
-60.65%-2.74M
-90.69%-3.11M
-202.32%-4.02M
---3.41M
---1.70M
---1.63M
Net Margin
-7539.33%-4534.90%
26.89%-2723.44%
-1.28%-2869.63%
99.90%-144.16%
---59.36%
-4312.56%-3725.17%
28.86%-2833.35%
-708306.78%-149373.77%
----
---84.42%
---3982.96%
--21.09%
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--0.00%
--154.43%
----
----
----
----
Revenue
-93.43%234.13K
48.97%243.75K
-2.61%251.15K
202768.80%3.96M
--3.56M
-95.22%163.62K
103.32%257.88K
-99.97%1.95K
--0.00
--3.43M
--126.84K
--6.00M
----
----
----
----
----
----
----
----
Operating profit
-469.95%-10.93M
-9.83%-7.05M
0.61%-7.63M
-4.34%-4.26M
56.93%-1.92M
-98.22%-6.41M
-40.65%-7.68M
-303.17%-4.08M
-24.87%-4.45M
-11.42%-3.24M
-88.20%-5.46M
224.47%2.01M
-41.05%-3.56M
15.72%-2.90M
-70.56%-2.90M
-0.96%-1.61M
-89.82%-2.53M
---3.45M
---1.70M
---1.60M
Net Profit
-401.82%-10.62M
-8.91%-6.64M
1.37%-7.21M
-95.78%-5.71M
47.39%-2.12M
-110.78%-6.09M
-44.63%-7.31M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
140.74%1.27M
14.89%-3.42M
9.30%-3.10M
-60.65%-2.74M
-90.69%-3.11M
-202.32%-4.02M
---3.41M
---1.70M
---1.63M
Current assets
22.00%39.07M
40.77%47.06M
38.80%53.26M
12.71%49.94M
-9.81%32.02M
-16.19%33.43M
2.78%38.37M
7.55%44.31M
200.33%35.51M
177.19%39.89M
115.40%37.33M
473.37%41.20M
35.80%11.82M
36.86%14.39M
--17.33M
--7.18M
--8.71M
--10.51M
----
----
Total current liabilities
47.11%5.39M
-21.97%3.51M
-18.30%3.55M
53.53%5.87M
58.13%3.67M
17.66%4.50M
0.51%4.34M
-24.30%3.82M
28.36%2.32M
213.24%3.83M
241.05%4.32M
32.13%5.05M
-29.89%1.81M
-23.03%1.22M
--1.27M
--3.82M
--2.58M
--1.59M
----
----
Total assets
22.70%39.32M
41.42%47.31M
38.71%53.27M
12.63%49.95M
-9.87%32.04M
-16.24%33.45M
2.71%38.40M
7.48%44.35M
198.87%35.55M
176.02%39.94M
114.67%37.39M
391.48%41.26M
31.23%11.90M
36.16%14.47M
--17.42M
--8.40M
--9.06M
--10.63M
----
----
Total liabilities
20.83%5.75M
-21.59%4.03M
-14.59%4.30M
45.12%6.92M
34.36%4.76M
9.83%5.14M
0.70%5.04M
-15.23%4.77M
96.04%3.54M
283.39%4.68M
294.84%5.00M
-66.49%5.63M
-87.47%1.81M
-89.85%1.22M
--1.27M
--16.79M
--14.42M
--12.03M
----
----
Total equity
23.03%33.57M
52.86%43.28M
46.75%48.97M
8.72%43.03M
-14.76%27.28M
-19.70%28.31M
3.01%33.37M
11.06%39.58M
217.28%32.01M
166.13%35.26M
100.55%32.39M
524.56%35.64M
288.32%10.09M
1042.04%13.25M
--16.15M
---8.39M
---5.36M
---1.41M
----
----
Net operating income
-539.94%-7.24M
-27.76%-7.38M
-119.52%-6.21M
58.21%-1.01M
79.30%-1.13M
-26.51%-5.77M
-231.80%-2.83M
-7.53%-2.41M
-146.44%-5.46M
-59.13%-4.56M
155.54%2.15M
-0.81%-2.24M
-39.24%-2.22M
-99.15%-2.87M
-94.68%-3.86M
-118.52%-2.22M
-22.78%-1.59M
---1.44M
---1.98M
---1.02M
Net investment
95.50%-23.24K
---1.66K
---885.00K
---648.61K
---516.00K
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
---25.00K
50.47%-193.19K
100.00%0.00
---350.00K
----
---390.00K
-57.29%-135.00K
----
----
--0.00
Net financing
-729.36%-120.44K
---166.07K
57356.17%11.00M
109.95%20.35M
133.97%19.14K
-100.00%0.00
-98.46%19.14K
-59.91%9.69M
---56.33K
--5.15M
-91.29%1.24M
23329.10%24.17M
100.00%0.00
-100.00%0.00
21947.26%14.25M
69.53%-104.07K
---9.81K
--9.54M
---65.23K
---341.58K

FAQs

What is the total revenue of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its total revenue reached 7.95M, with a year-on-year change of 3.55M.

What are the current assets of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its current assets were 49.94M, with a year-on-year change of 12.71.

What are the total assets of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its total assets of Coya Therapeutics Inc were 49.95M, with a year-on-year change of 12.63.

What are the total liabilities of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its total liabilities of Coya Therapeutics Inc were 6.92M, with a year-on-year change of 45.12.

What is the total equity of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its total equity of Coya Therapeutics Inc was 43.03M, with a year-on-year change of 8.72.

What is the net operating income of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its net operating income of Coya Therapeutics Inc was -20.27M, with a year-on-year change of -17.65.

What is the net investment of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its net investment of Coya Therapeutics Inc was -1.16M, with a year-on-year change of -4558.41.

What is the net financing of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its net financing of Coya Therapeutics Inc was 20.39M, with a year-on-year change of 27.21.

What is the Earnings Per Share (EPS) of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.27, with a year-on-year change of -29.93.

What is the net income of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its net income was -21.23M, with a year-on-year change of -42.64.

What is the net margin of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its net profit margin was -267.14, with a year-on-year change of 36.20.

What is the Return on Equity (ROE) of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -51.39, with a year-on-year change of -29.88.

What is the Return on Assets (ROA) of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.02, with a year-on-year change of -29.50.

What is the operating profit of Coya Therapeutics Inc?

According to Coya Therapeutics Inc's FY2025 earnings report, its operating profit was -20.27M, with a year-on-year change of -17.65.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.